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TO THE EDITOR
Tumor-associated macrophages are
important factors driving melanoma
progression once neoplastic conversion
has been initiated (Ly et al., 2010; Zaidi
et al., 2011; Clifford et al., 2013; Kiyota
et al., 2014; Tham et al., 2015). There
is another aspect of macrophage beha-
vior potentially related to melanoma.
After neonatal UVR exposure in mice,
an inﬂux of macrophages into the skin
plays a part in enhancing melanocyte
proliferation (Zaidi et al., 2011). It is
speculated that activation of melano-
cytes after UVR is a component of the
UVR damage response that increases
melanoma risk after acute sunburn
(Zaidi et al., 2011; Handoko et al.,
2013), and that targeting macrophages
after sunburn may be a means of
lowering that risk (Wang and Herlyn,
2013). This is of interest as human and
animal work shows that sun exposure
in the early life increases melanoma risk
(Noonan et al., 2001; Whiteman et al.,
2001). A link between the immune
system and melanoma “initiation” is
attractive, as neonatal UVR reduces
delayed-type hypersensitivity immune
responses, resulting in persistent immune
tolerance that could favor tumorigenesis
(McGee et al., 2011).
Using wild-type mice, Zaidi et al.
(2011) elegantly associated macrophage
inﬁltration with melanocyte prolifera-
tion after neonatal UVR exposure, and
then showed that macrophages sorted
from UVR-exposed neonatal mice, when
mixed with melanoma cells, exacerbated
tumor growth upon transplantation. The
melanocyte response to UVR manifests as
activation and proliferation of upper hair
follicle precursors, and their migration
to the epidermis (Walker et al., 2009).
We conﬁrmed the macrophage–melano-
cyte link by injecting clodronate-
ﬁlled liposomes into the skin of neonatal
mice (Handoko et al., 2013). Clodronate
induces macrophage apoptosis, and is the
major experimental means of targeting
macrophages to demonstrate their role
in promoting tumor progression (see,
e.g., Kruse et al., 2013; Fritz et al.,
2014), including in melanoma (Ly et al.,
2010; Kiyota et al., 2014). We showed
that clodronate-liposome treatment signif-
icantly diminished the melanocyte res-
ponse (Handoko et al., 2013). However,
both we and Zaidi et al. (2011) used wild-
type mice that do not develop melanoma
after neonatal UVR. Thus, we hypothe-
sized that with a melanoma-prone mouse
model we could use macrophage deple-
tion as a tool to determine whether the
melanocyte activation inﬂuences mela-
noma development, and whether deple-
tion of macrophages after sunburn may be
a potential prevention strategy.
We utilized Cdk4R24C::Tyr-NRASQ61K
mice, in whichmelanomagenesis is greatly
accelerated by a single neonatal UVB
exposure (Ferguson et al., 2010). The miceAccepted article preview online 2 June 2015; published online 18 June 2015
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also carry congenital nevi that manifest as
nests of melanocytic cells in the superﬁcial
dermis (Wurm et al., 2012). Pups were
exposed at postnatal day 3 to a single dose
(5.9 kJm−2) of UVB and followed until
they developed melanoma. Surprisingly,
we found that injection of clodronate-
liposomes 1 day before, the day of, and
2 days after UVR did not slow melanoma
development. This work was approved by
the QIMR Berghofer Animal Ethics Com-
mittee (A98004M).
We followed 27 mice injected
with clodronate-liposomes and 20 with
phosphate-buffered saline (PBS)-lipo-
somes, and saw no difference in mela-
noma age of onset (Figure 1a), or the
mean number of primary lesions per
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animal (Figure 1b). Nor did we observe
histopathological differences in melano-
mas between groups (Supplementary
Figure S1 online). Epidermal melanocyte
count at 4 days after UVR exposure was
signiﬁcantly reduced in Cdk4R24C/R24C
mice (which do not develop melanoma),
and in littermate melanoma-prone
Cdk4R24C::Tyr-NRASQ61K mice, after
clodronate treatment (Figure 1c and d).
Unsurprisingly, clodronate depleted
macrophages (by 450%) in Cdk4R24C::
Tyr-NRASQ61K neonatal mouse skin
(Figure 1d and e).
It is believed that neonatal UVR
accelerates melanoma partly via recruit-
ment of macrophages that stimulate
melanocyte proliferation. However, in
our system clodronate treatment dam-
pened the melanocyte response, but
did not slow melanoma development.
Clearly, tumor-inﬁltrating macrophages
enhance melanoma progression once a
tumor is formed. Clodronate-liposome
treatment reduces tumor growth in many
experimental cancers (see, e.g., Kruse
et al., 2013; Fritz et al., 2014). However,
these studies differ from ours in that
they depleted macrophages in esta-
blished tumors, and often the period of
clodronate treatment lasted for weeks.
We injected clodronate-liposomes during
the neonatal period when macrophages
drive melanocyte proliferation. Since
both macrophage (Rodero et al., 2013)
and epidermal melanocyte density
(Walker et al., 2009) peak at 4 days,
and return to steady state by 7 days after
neonatal UVR, the period when the
macrophages inﬂuences melanocyte
behaviour is, in the absence of further
UVR-induced damage, only within the
few days post UVR. Based on density of
macrophages within the skin of the
melanoma-prone mice (Figure 1f), mye-
loid cells appear active either imme-
diately after UVR, or when melanoma
has formed, even in very early lesions
(Figure 1f). Notably, macrophage density
is extremely low in benign nevi of
Cdk4R24C::Tyr-NRASQ61K mice, support-
ing the notion that only the onset of
neoplasia invokes macrophage inﬁltra-
tion. Whether long-term application of
clodronate for macrophage depletion
during the life of the mouse would slow
the development of melanoma is an open
question. However, this would not test
the potential melanoma-promoting effects
of inﬁltrating macrophages, and activation
of melanocytes, just after neonatal UVR
treatment. Perversely, a study that per-
formed long-term clodronate treatment in
a transgenic skin cancer model found that
macrophage depletion exacerbated basal
cell carcinoma development (König et al.,
2014).
Our study differed from the study that
initially established the macrophage–
melanocyte link (Zaidi et al., 2011).
They did not target macrophages per se,
but utilized antibody-mediated blocking
of IFNγ (IFNG) signaling to prevent
melanocyte activation, as IFNG is pro-
duced by the inﬁltrating macrophages.
They did not test whether blocking IFNG
during the neonatal period inﬂuences
subsequent melanoma development in a
melanoma-prone model. Impressively
though, neonatal UVR-induced macro-
phages did, upon transplantation, pro-
mote tumorigenesis when mixed with
transformed cells. Possibly blocking IFNG
signaling after sunburn (instead of macro-
phage depletion as we have done) may
slow melanoma development.
In conclusion, we further conﬁrm the
importance of macrophages in melano-
cyte activation. Notwithstanding their
established roles in promoting tumor
progression and spread, using the
most common method of macrophage
depletion we do not ﬁnd evidence
that macrophages, or the melanocyte
response associated with them, play a
large role in accelerating UVR-induced
melanoma development in an auto-
chthonous mouse model. Speciﬁc tar-
geting of macrophages after sunburn
may not protect against melanoma.
Figure 1. Depletion of macrophages inﬁltrating the skin after a single neonatal UVB irradiation does not slow melanoma development. (a) Kaplan–Meier
plot showing melanoma-free survival for Cdk4R24C::Tyr-NRASQ61K transgenic mice treated with either clodronate (Clod, n=27) or phosphate-buffered saline
(PBS, n= 20) as controls. Pups were injected with 5 mgml−1 clodronate- or PBS-ﬁlled liposome suspension (ClodronateLiposomes.com, Haarlem, The
Netherlands), 30 μl intraperitoneally and 30 μl subcutaneously, 1 day before UVR, on the day of UVR, and 2 days after UVR exposure (Handoko et al. 2013).
Melanoma onset is when each mouse developed a melanoma of 8–10mm in diameter (on average 2 weeks after the ﬁrst visual observation of melanoma).
P-value for difference in melanoma-free survival between groups was calculated with the log-rank (Mantel–Cox) test using GraphPad Prism 6 (GraphPad
Software, La Jolla, CA). (b) Comparison of the mean number primary melanomas between control (PBS) and Clod-treated groups. The box-and-whiskers graph
shows median, 25 and 75% percentiles within the box; and the whiskers show the largest and smallest values. Signiﬁcance of difference between means was
calculated with unpaired t-test using GraphPad Prism 6. (c) Comparison of melanocyte count per ﬁeld in the interfollicular epidermis at day 4 after neonatal UVR,
for Cdk4R24C and Cdk4R24C::Tyr-NRASQ61K transgenic mice, respectively, treated with either PBS-ﬁlled liposomes (PBS), or clodronate-ﬁlled liposomes (Clod).
Counts were performed on multiple ﬁelds from multiple skin sections from each of 43 mice (each ﬁeld is ~ 1mm in length). (d) Images of skin showing
macrophages (red–brown) at day 4 after neonatal UVR, stained with F4/80 (ab6640, Abcam, Cambridge, UK). Lower panels indicate melanocytes at day 4 after
neonatal UVR (red–brown nuclei) stained with Sox10 (N-20, Santa Cruz Biotechnology, Santa Cruz, CA). Parafﬁn-embedded sections were dewaxed and treated
with Dako Target Retrieval Solution (Carpinteria, CA) at 110 °C for 10min. Secondary detection was via Biocare Medical probe and polymer (Concord, CA) that
was visualized using ImmPACT DAB (SK-4105, Vector Laboratories, Burlingame, CA). Yellow arrows indicate F4/80-positive macrophages, red arrows indicate
epidermal basal layer melanocytes, and green arrows indicate melanocytes around the bulge or infundibulum of the hair follicle. Scale bar=100 μm. (e)
Macrophage count per ﬁeld in neonatal skin and in adult skin and melanocytic lesions. Columns at left indicate average macrophage count at 4 days (4d) after
neonatal UVR in mice treated with PBS or Clod (n=4 and 4 mice, respectively). Next, macrophage count in normal skin of the animals at the time of killing
(i.e., they had developed a melanoma). The average age of onset for both PBS (n= 12) and Clod (n= 12) groups selected was ~ 150 days (150d). Subsequent
columns indicate macrophage count in congenital nevi. Finally, columns at far right show macrophage count in melanomas in animals injected with either PBS
(n= 12) or Clod (n= 12) at the time of neonatal UVR. (f) Macrophages in the skin at various times of tumor progression in Cdk4R24C::Tyr-NRASQ61K mice after
neonatal UVR. Sections were stained with F4/80 (red–brown). Yellow arrows indicate dense inﬁltrations of macrophages. Normal skin and congenital nevi (the
same samples tested in e) contain either none or only scattered single macrophages. The dense inﬁltrations of macrophages are limited to the few days after
neonatal UVR, and once frank neoplasia has commenced. Red arrows denote nevus cells in the superﬁcial dermis. Scale bar=100 μm. MM, melanoma.
HY Handoko et al.
UVR-Induced Melanocyte Proliferation and Melanoma
www.jidonline.org 2899
CONFLICT OF INTEREST
The authors state no conﬂict of interest.
ACKNOWLEDGMENTS
This work was funded by a grant from the Cancer
Council of Queensland (CCQ) and the National
Health and Medical Research Council of Australia
(NHMRC). KK is supported by an NHMRC career
development fellowship.
Herlina Y. Handoko1,
Mathieu P. Rodero2,
H. Konrad Muller3,
Kiarash Khosrotehrani2,4,5 and
Graeme J. Walker1,5
1QIMR Berghofer Medical Research Institute,
Herston, Queensland, Australia; 2The
University of Queensland, UQ Centre for
Clinical Research, Herston, Queensland,
Australia; 3School of Medicine, University of
Tasmania, Hobart, Tasmania, Australia and
4The University of Queensland, UQ Diamantina
Institute, Translational Research Institute,
Woolloongabba, Queensland, Australia
E-mail: Graeme.Walker@qimr.edu.au
5The last two authors contributed equally to
this work.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Clifford AB, Elnaggar AM, Robison RA et al. (2013)
Investigating the role of macrophages in tumor
formation using a MaFIA mouse model. Oncol
Rep 30:890–6
Ferguson B, Muller HK, Handoko HY et al. (2010)
Differential roles of the pRb and Arf/p53
pathways in murine naevus and melanoma
genesis. Pigment Cell Melanoma Res 23:
771–80
Fritz JM, Tennis MA, Orlicky DJ et al. (2014)
Depletion of tumor-associated macrophages
slows the growth of chemically induced
mouse lung adenocarcinomas. Front Immunol
25:587
Handoko HY, Rodero MP, Boyle G et al. (2013)
UVB-induced melanocyte proliferation in
neonatal mice driven by CCR2-independent
recruitment of Ly6clowMHCIIhi macrophages.
J Invest Dermatol 133:1803–12
Kiyota T, Takahashi Y, Watcharanurak K et al. (2014)
Enhancement of anticancer effect of interferon-
γ gene transfer against interferon-γ-resistant
tumor by depletion of tumor-associated macro-
phages. Mol Pharm 11:1542–9
König S, Nitzki F, Uhmann A et al. (2014) Depletion
of cutaneous macrophages and dendritic cells
promotes growth of basal cell carcinoma
in mice. PLoS One 9:e93555
Kruse J, von Bernstorff W, Evert K et al. (2013)
Macrophages promote tumour growth and
liver metastasis in an orthotopic syngeneic
mouse model of colon cancer. Int J Colorectal
Dis 28:1337–49
Ly LV, Baghat A, Versluis M et al. (2010) In aged
mice, outgrowth of intraocular melanoma
depends on proangiogenic M2-type macro-
phages. J Immunol 185:3481–8
McGee HM, Malley RC, Muller HK et al. (2011)
Neonatal exposure to UVR alters skin immune
system development, and suppresses immunity
in adulthood. Immunol Cell Biol 89:767–76
Noonan FP, Recio JA, Takayama H et al. (2001)
Neonatal sunburn and melanoma in mice.
Nature 413:271–2
Rodero MP, Handoko HY, Villani RM et al. (2014)
Differential effects of ultraviolet irradiation in
neonatal versus adult mice are not explained
by defective macrophage or neutrophil inﬁl-
tration. J Invest Dermatol 134:1991–7
Tham M, Khoo K, Yeo KP et al. (2015) Macro-
phage depletion reduces postsurgical tumor
recurrence and metastatic growth in a
spontaneous murine model of melanoma.
Oncotarget; advance online publication, PMID:
25762633
Walker GJ, Kimlin MG, Hacker E et al. (2009)
Murine neonatal melanocytes exhibit a
heightened proliferative response to ultra-
violet radiation and migrate to the epidermal
basal layer. J Invest Dermatol 129:184–93
Wang T, Herlyn M (2013) The macrophage: a new
factor in UVR-induced melanomagenesis.
J Invest Dermatol 133:1711–3
Whiteman DC, Whiteman CA, Green AC
(2001) Childhood sun exposure as a risk factor
for melanoma: a systematic review of epide-
miologic studies. Cancer Causes Control 12:
69–82
Wurm EM, Lin LL, Ferguson B et al. (2012) A
blueprint for staging of murine melanocytic
lesions based on the Cdk4(R24C/R24C)::
Tyr-NRAS (Q61K) model. Exp Dermatol 21:
676–81
Zaidi MR, Davis S, Noonan FP et al. (2011)
Interferon-γ links ultraviolet radiation to mel-
anomagenesis in mice. Nature 469:548–53
HY Handoko et al.
UVR-Induced Melanocyte Proliferation and Melanoma
2900 Journal of Investigative Dermatology (2015), Volume 135
